{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:25:02Z","timestamp":1783074302842,"version":"3.54.6"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T00:00:00Z","timestamp":1545436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"GlaxoSmithKline Biologicals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Oropharyngeal cancer incidence is rapidly rising due to human papillomavirus (HPV) type 16 infection. The dearth of data on effectiveness of national female-only vaccination programs in preventing oral HPV infection and potential herd immunity in unvaccinated males has resulted in considerable controversy regarding the need to vaccinate males, especially in countries with high female vaccination coverage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Subjects aged 0\u201365 years undergoing tonsillectomy for nonmalignant indications were recruited in 6 hospitals in the United Kingdom. Oral samples were collected as follows: oral rinse, tongue base, and pharyngeal wall brushes, then tonsil tissue (tonsillectomy). Vaccination data were obtained from regional health authorities. All samples were centrally tested for HPV DNA by polymerase chain reaction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 940 subjects, 243 females and 69 males were aged 12\u201324 years (median age, 18.6 years), with 189 (78%) females and no males vaccinated against HPV. Overall, oropharyngeal HPV-16 prevalence was significantly lower in vaccinated versus unvaccinated females (0.5% vs 5.6%, P = .04). In contrast, prevalence of any oropharyngeal HPV type was similar in vaccinated and unvaccinated females (19% vs 20%, P = .76). Oropharyngeal HPV-16 prevalence in unvaccinated males was similar to vaccinated females (0% vs 0.5%, P &gt; .99), and lower than unvaccinated females (0% vs 5.6%, P = .08).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings indicate that the UK female-only vaccination program is associated with significant reductions in oropharyngeal HPV-16 infections. These are also the first data to suggest potential herd immunity from female-only vaccination against oropharyngeal HPV infection in contemporaneously aged males.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciy1081","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T13:50:25Z","timestamp":1545400225000},"page":"1296-1302","source":"Crossref","is-referenced-by-count":49,"title":["Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study"],"prefix":"10.1093","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5544-6224","authenticated-orcid":false,"given":"Hisham","family":"Mehanna","sequence":"first","affiliation":[{"name":"Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet","family":"Babrah","sequence":"additional","affiliation":[{"name":"Cancer Research UK Clinical Trials Unit, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly","family":"Louie","sequence":"additional","affiliation":[{"name":"Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Bryant","sequence":"additional","affiliation":[{"name":"Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J","family":"Spruce","sequence":"additional","affiliation":[{"name":"Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Batis","sequence":"additional","affiliation":[{"name":"Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladejo","family":"Olaleye","sequence":"additional","affiliation":[{"name":"Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Jones","sequence":"additional","affiliation":[{"name":"Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Struijk","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory, Rijswijk, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anco","family":"Molijn","sequence":"additional","affiliation":[{"name":"DDL Diagnostic Laboratory, Rijswijk, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[{"name":"Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, GlaxoSmithKline, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rosillon","sequence":"additional","affiliation":[{"name":"Clinical and Epidemiology Research Development, GlaxoSmithKline, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Taylor","sequence":"additional","affiliation":[{"name":"Clinical and Epidemiology Research Development, GlaxoSmithKline, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gypsyamber","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"2019092701014895500_CIT0001","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N Engl J Med"},{"key":"2019092701014895500_CIT0002","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019092701014895500_CIT0003","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2019092701014895500_CIT0004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2014systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"2019092701014895500_CIT0005","doi-asserted-by":"crossref","first-page":"E1863","DOI":"10.1002\/hed.24336","article-title":"Geographic variation in human papillomavirus-related oropharyngeal cancer: data from 4 multinational randomized trials","volume":"38(Suppl 1)","author":"Mehanna","year":"2016","journal-title":"Head Neck"},{"key":"2019092701014895500_CIT0006","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"2019092701014895500_CIT0007","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"key":"2019092701014895500_CIT0008","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"2019092701014895500_CIT0009","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"2019092701014895500_CIT0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/cid\/cir1036","article-title":"Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study","volume":"54","author":"Swedish","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2019092701014895500_CIT0011","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ygyno.2008.06.029","article-title":"Impact of vaccination with Cervarix (trade mark) on subsequent HPV-16\/18 infection and cervical disease in women 15-25 years of age","volume":"110","author":"Harper","year":"2008","journal-title":"Gynecol Oncol"},{"key":"2019092701014895500_CIT0012","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","author":"Kavanagh","year":"2014","journal-title":"Br J Cancer"},{"key":"2019092701014895500_CIT0013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"2019092701014895500_CIT0014","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4161\/hv.7.12.18282","article-title":"Comparison of the immunogenicity of the human papillomavirus (HPV)-16\/18 vaccine and the HPV-6\/11\/16\/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years","volume":"7","author":"Einstein","year":"2011","journal-title":"Hum Vaccin"},{"key":"2019092701014895500_CIT0015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","article-title":"Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study","volume":"17","author":"Kavanagh","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019092701014895500_CIT0016","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"2019092701014895500_CIT0017","first-page":"1","article-title":"Gardasil 9: EPAR summary for the public.","author":"European Medicines Agency","year":"2015"},{"key":"2019092701014895500_CIT0018","volume-title":"Human papillomavirus (HPV) vaccine coverage in England, 2008\/09 to 2013\/14: a review of the full six years of the three-dose schedule","author":"Public Health England","year":"2015"},{"key":"2019092701014895500_CIT0019","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2019092701014895500_CIT0020","doi-asserted-by":"crossref","first-page":"e009915","DOI":"10.1136\/bmjopen-2015-009915","article-title":"Continuing reductions in HPV 16\/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study","volume":"6","author":"Mesher","year":"2016","journal-title":"BMJ Open"},{"key":"2019092701014895500_CIT0021","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jiy249","article-title":"The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010\u20132016","volume":"218","author":"Mesher","year":"2018","journal-title":"J Infect Dis"},{"key":"2019092701014895500_CIT0022","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/bjc.2014.479","article-title":"Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland","volume":"111","author":"Pollock","year":"2014","journal-title":"Br J Cancer"},{"key":"2019092701014895500_CIT0023","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiy067","article-title":"High effectiveness of the bivalent human papillomavirus (HPV) vaccine against incident and persistent HPV infections up to 6 years after vaccination in young Dutch women","volume":"217","author":"Donken","year":"2018","journal-title":"J Infect Dis"},{"key":"2019092701014895500_CIT0024","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ijc.31231","article-title":"Vaccination protects against invasive HPV-associated cancers","volume":"142","author":"Luostarinen","year":"2018","journal-title":"Int J Cancer"},{"key":"2019092701014895500_CIT0025","doi-asserted-by":"crossref","first-page":"e68329","DOI":"10.1371\/journal.pone.0068329","article-title":"Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica","volume":"8","author":"Herrero","year":"2013","journal-title":"PLoS One"},{"key":"2019092701014895500_CIT0026","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","article-title":"Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States","volume":"36","author":"Chaturvedi","year":"2018","journal-title":"J Clin Oncol"},{"key":"2019092701014895500_CIT0027","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2019092701014895500_CIT0028","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0002-9440(10)65688-X","article-title":"Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses","volume":"153","author":"Kleter","year":"1998","journal-title":"Am J Pathol"},{"key":"2019092701014895500_CIT0029","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1128\/JCM.02831-12","article-title":"A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay","volume":"51","author":"van Alewijk","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2019092701014895500_CIT0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-9378-4-7","article-title":"The evolving definition of carcinogenic human papillomavirus","volume":"4","author":"Castle","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"2019092701014895500_CIT0031","volume-title":"HN03-03 efficacy of AS04-adjuvanted HPV-16\/18 vaccine in reducing oropharyngeal HPV infections in adolescent girls\u2014results from a community-randomized trial","author":"Lehtinen","year":"2017"},{"key":"2019092701014895500_CIT0032","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/M17-1363","article-title":"Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014","volume":"167","author":"Sonawane","year":"2017","journal-title":"Ann Intern Med"},{"key":"2019092701014895500_CIT0033","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","article-title":"Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009\u20132013","volume":"22","author":"Cameron","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2019092701014895500_CIT0034","article-title":"Sexually transmitted infections and chlamydia screening in England, 2016. London: Public Health England,","year":"2017"},{"key":"2019092701014895500_CIT0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archoto.2009.49","article-title":"Prevalence of oncogenic human papillomavirus 16 and 18 in the palatine tonsils of the general adult population","volume":"135","author":"Ernster","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2019092701014895500_CIT0036","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2559.2010.03576.x","article-title":"p16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV","volume":"56","author":"Klingenberg","year":"2010","journal-title":"Histopathology"},{"key":"2019092701014895500_CIT0037","first-page":"305","article-title":"Screening for HPV in clinically benign tonsillectomy specimens","volume":"25","author":"Bekker","year":"2012","journal-title":"Modern Pathol"},{"key":"2019092701014895500_CIT0038","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/annonc\/mdx304","article-title":"Human papillomavirus-related oropharyngeal cancer","volume":"28","author":"Taberna","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/8\/1296\/30063292\/ciy1081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T01:39:49Z","timestamp":1605749989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/8\/1296\/5257796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,22]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,12,22]]},"published-print":{"date-parts":[[2019,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1081","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,15]]},"published":{"date-parts":[[2018,12,22]]}}}